Journey Medical (DERM) Enterprise Value (2020 - 2025)
Journey Medical (DERM) has disclosed Enterprise Value for 6 consecutive years, with -$24.9 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Enterprise Value fell 11.07% year-over-year to -$24.9 million, compared with a TTM value of -$24.9 million through Sep 2025, down 11.07%, and an annual FY2024 reading of -$20.3 million, up 25.89% over the prior year.
- Enterprise Value was -$24.9 million for Q3 2025 at Journey Medical, down from -$20.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$17.0 million in Q2 2023 and bottomed at -$49.1 million in Q4 2021.
- Average Enterprise Value over 5 years is -$27.1 million, with a median of -$24.1 million recorded in 2024.
- The sharpest move saw Enterprise Value tumbled 498.55% in 2021, then skyrocketed 57.99% in 2023.
- Year by year, Enterprise Value stood at -$49.1 million in 2021, then soared by 34.8% to -$32.0 million in 2022, then grew by 14.37% to -$27.4 million in 2023, then rose by 25.89% to -$20.3 million in 2024, then fell by 22.87% to -$24.9 million in 2025.
- Business Quant data shows Enterprise Value for DERM at -$24.9 million in Q3 2025, -$20.3 million in Q2 2025, and -$21.1 million in Q1 2025.